Krystal Biotech Inc (KRYS) — Cash Flow Reinvestment Rate
Krystal Biotech Inc (KRYS) has a Cash Flow Reinvestment Rate of 0.79x as of March 2026, reinvesting $63.58 Million (capex $7.15 Million plus investments $-56.44 Million) from operating cash flow of $80.38 Million. Explore Krystal Biotech Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Krystal Biotech Inc Cash Flow Reinvestment Rate (2024–2025)
Historical reinvestment intensity for Krystal Biotech Inc across 2 annual periods. Also explore Krystal Biotech Inc total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Krystal Biotech Inc (2024–2025)
Year-by-year capital reinvestment analysis for Krystal Biotech Inc. For live market cap and broader valuation context, see Krystal Biotech Inc (KRYS) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.29x | $58.85 Million | $200.87 Million | $11.95 Million | ▼ -78.4% |
| 2024 | 1.36x | $167.68 Million | $123.42 Million | $4.24 Million | — |